| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.06 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.095 | 0.06 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.28 | 0.08 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |